Petros Pharmaceuticals, Inc. Inventory, Finished Goods, Net of Reserves
Petros Pharmaceuticals, Inc. (PTPI) had Inventory, Finished Goods, Net of Reserves of $85.91 thousand as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2025-03-31
- 2024-12-31: Inventory, Finished Goods, Net of Reserves $85.91K.
- 2024-09-30: Inventory, Finished Goods, Net of Reserves $148.50K.
- 2024-06-30: Inventory, Finished Goods, Net of Reserves $112.11K.
- 2024-03-31: Inventory, Finished Goods, Net of Reserves $143.40K.
| Period end | Inventory, Finished Goods, Net of Reserves | Inventory, Finished Goods, Net of Reserves as first filed |
|---|---|---|
| 2024-12-31 | $85.91K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $148.50K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $112.11K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $143.40K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $180.25K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $109.90K 10-Q · filed 2023-11-15 | |
| 2023-06-30 | $98.92K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $125.50K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $240.43K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $673.98K 10-Q/A · filed 2022-11-15 | |
| 2022-06-30 | $368.44K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $386.89K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $159.91K 10-K · filed 2023-03-31 | $383.30K 10-K · filed 2022-03-31 |
| 2021-09-30 | $435.93K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $546.67K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $941.54K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $935.87K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |